Navigation Links
Scientist Warns Industry Not to Ignore Potential Health Threat to Pharmacy Workers
Date:11/10/2008

- Recently issued study that found retail pharmacy workers are exposed to

airborne pharmaceutical agents needs further review -

DREXEL, Mo., Nov. 10 /PRNewswire/ -- AlburtyLab's President, David Alburty issued a statement today regarding serious concerns about efforts by McKesson/Parata to misrepresent and diminish the potential health threats that pharmacy workers face when they work in pharmacies using air pressure driven dispensing machines.

Statement by David Alburty:

Communications recently issued by McKesson/Parata regarding potential exposure of pharmacy workers to airborne pill dust when they use air pressure driven drug dispensing machines attempt to mask a potentially serious health matter affecting pharmacy workers.

McKesson/Parata claims that unreleased tests they performed, not conducted by Occupational Safety and Health Administration (OSHA) but "under OSHA standards (set by *1 NIOSH)," are relevant to this issue. They are not.

It is critical to know that OSHA air quality regulations are limited to general guidelines for "nuisance dust" such as emissions from grinding and burning processes. There are no OSHA standards establishing safe quantities of pharmaceutical compounds in the air. Nor are there OSHA standards for PM-2.5 particles and nanoparticles. These very small particles, which are used to transport pharmaceutical agents, have been shown to be generated when pills are subjected to air pressure dispensing.

PM-2.5 particles are the subject of EPA air quality standards and World Health Organization guidelines because they penetrate the lungs deeply and rapidly enter the bloodstream. As documented in our (AlburtyLab, October 2008) study, these particles are believed to cause a number of serious health problems. The fact that OSHA standards do not yet address this issue does not mean that it should be ignored.

Our study unveiled potentially serious exposures for pharmacy workers, and our strong recommendation is that the issue needs to be studied by federal regulatory agencies. As reported by the publication Inside OSHA on October 27, 2008, "A NIOSH official says that he believes pharmacists are being exposed to harmful particles." He further stated, "The agency advises against using technology that produces any type of particulate that could be inhaled."

The official described our study as "fairly straightforward" and said that there is concern that drugs involved were "not meant to be inhaled."

Clearly, federal regulatory agencies must assess risk and set guidelines for these types of machines and establish procedures to monitor the health impact on pharmacy workers when they are used.

The previous press release, the executive summary and the full study are available for review.

http://www.alburtylab.com

About AlburtyLab, Inc.

AlburtyLab is an independent laboratory located in Drexel, Missouri that serves the aerosol research, development, and instrumentation communities. AlburtyLab has conducted independent studies for a range of agencies and companies, including Boeing/US Navy, Boston Scientific, Northrop Grumman, US Postal Service, US Department of Homeland Security, and the US Army Research Laboratory.

Technical questions may be directed to Mr. Alburty at (816) 619-3374 or via email to dalburty@alburtylab.com.

This study was funded by one of the technologies reviewed in the evaluation, ScriptPro LLC of Mission, Kansas.

The Executive Summary and the final report can be found at http://www.alburtylab.com

*1 NIOSH (National Institute of Occupational Safety and Health) that created testing specifications required by OSHA.

Contact: Josh Fenton, The Fenton Group

Tel. 401-490-4888/401-497-0186

jfenton@thefentongroup.net


'/>"/>
SOURCE AlburtyLab, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... soon after surgery as possible. With this in mind, SIGVARIS has created a ... or blood clot) during bed rest and provide the benefits of graduated compression ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dianne Michael ... headquartered in Hamilton County, is embarking on a charity drive with the aim ... new homes for orphaned or neglected senior dogs in the Cincinnati region, and ...
(Date:12/8/2016)... Louis, MS (PRWEB) , ... December 08, 2016 , ... ... that serve commercial and residential clients in and around the Hancock County area, is ... for the Hancock County Food Pantry. , The Hancock County Food Pantry has worked ...
(Date:12/7/2016)... ... December 07, 2016 , ... Students ... have the unique opportunity to get hands-on experience in an emergency medical simulation, ... immersive experience to gain invaluable, real-life medical skills that are critical success in ...
(Date:12/7/2016)... LA (PRWEB) , ... December 07, 2016 , ... ... used to treat wrinkles and deep lines by smoothing and tightening the skin ... invasive techniques out there to address facial aging with very little downtime, Silhouette ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... -- Eli Lilly and Company (NYSE: LLY ) ... trial at the 9 th Clinical Trials on ... not meet the primary endpoint in the EXPEDITION3 clinical ... mild dementia due to Alzheimer,s disease (AD), and Lilly ... treatment of mild dementia due to AD. ...
(Date:12/8/2016)... Mass. , Dec. 8, 2016   ... that Nationwide Children,s Hospital signed a ... and accelerate the development of new cures. ... organizations representing over 57 million patients globally, biopharmaceutical ... working together to improve protocol design, site selection, ...
(Date:12/8/2016)... 8, 2016  A new study by a pair ... of opioid therapy to treat chronic pain is not ... more harmful consequences, including death. Palliative care ... Zankhana Mehta , M.D., authored the study which provides ... therapy. The study was published in the December 2016 ...
Breaking Medicine Technology: